| Review of medical abortion using mifepristone in combination with a prostaglandin analogue. | |
| | |
MedLine Citation:
|
PMID: 16781264 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Induced abortion is still a major health problem in the world and the most frequently performed intervention in obstetrics and gynecology with an estimated total of 46 million worldwide each year. Medical abortion with mifepristone and prostaglandin was first introduced in 1988 and is now approved in 31 countries. This combination of drugs has recently been included in the List of Essential Medicines by the World Health Organisation. The present review summarizes the development, physiology and the development of the currently used regimens. |
| | |
Authors:
|
Christian Fiala; Kristina Gemzel-Danielsson |
Related Documents
:
|
18072704 - "when doing good is just the start to being good": a possible tool to improve the organ... 7787194 - Reflection on the definition of impairment and disability as defined by the world healt... 11143614 - The future in health care delivery. lessons from history, demographics, and economics. 11618844 - Galaxy of health hazards in various socio-cultural scenario. 16919094 - A preliminary investigation into tooth care, dental attendance and oral health related ... 2060474 - Reasons for tooth extraction among tanzanians. |
Publication Detail:
|
Type: Journal Article; Review Date: 2006-05-19 |
Journal Detail:
|
Title: Contraception Volume: 74 ISSN: 0010-7824 ISO Abbreviation: Contraception Publication Date: 2006 Jul |
Date Detail:
|
Created Date: 2006-06-19 Completed Date: 2006-11-22 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0234361 Medline TA: Contraception Country: United States |
Other Details:
|
Languages: eng Pagination: 66-86 Citation Subset: IM |
Affiliation:
|
Gynmed Clinic, Mariahilferguertel 37, A-1150 Vienna, Austria. christian.fiala@aon.at |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abortifacient Agents, Nonsteroidal
/
administration & dosage Abortifacient Agents, Steroidal / administration & dosage* Abortion, Induced / methods* Administration, Intravaginal Administration, Sublingual Analgesia, Obstetrical Female Gestational Age Humans Mifepristone / administration & dosage*, adverse effects, pharmacokinetics Misoprostol / administration & dosage, adverse effects, pharmacokinetics Patient Satisfaction Pregnancy Prostaglandins / administration & dosage* Time Factors Uterine Contraction / drug effects Uterine Hemorrhage World Health Organization |
| Chemical | |
Reg. No./Substance:
|
0/Abortifacient Agents, Nonsteroidal; 0/Abortifacient Agents, Steroidal; 0/Prostaglandins; 59122-46-2/Misoprostol; 84371-65-3/Mifepristone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Medical abortion in early pregnancy: experience in China.
Next Document: Earthquakes.